AGILENT TECHNOLOGIES, INC. is 4.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($37.02 B vs $8.09 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BIO | A |
|---|---|---|
| Market cap | $8.09 B | $37.02 B |
| US-listed rank | #1070 | #407 |
| Revenue (latest FY) | $2.58B | $6.95B |
| Net income (latest FY) | $759.90M | $1.30B |
| Net margin | 29.4% | 18.8% |
| P/E (trailing FY) | 10.6 | 28.4 |
| SEC filings | 1,494 | 2,339 |
AGILENT TECHNOLOGIES, INC. is 4.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($37.02 B vs $8.09 B).
In their latest fiscal years, Bio-Rad Laboratories, Inc. reported $2.58B in revenue while AGILENT TECHNOLOGIES, INC. reported $6.95B.
Full pages: Bio-Rad Laboratories, Inc. and AGILENT TECHNOLOGIES, INC., or browse the full rankings.